Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
92 Cards in this Set
- Front
- Back
Among which group is use of Rx drugs increasing?
|
increasing rates among drinkers and recreational drug users
|
|
What are the most commonly used Rx psychoactive drugs?
|
opioids, tranquilizers, stimulants
|
|
What's the definition of physiological dependence?
|
evidence of tolerance or withdrawal
|
|
what's the definition of psychological dependence?
|
evidence of a persistent or repeated compulsion to use despite seemingly adverse consequences
|
|
what's substance abuse?
|
maladaptive pattern of substance use that causes significant impairment (social or occupational) or physical hazard (driving while intoxicated
|
|
what's substance dependence?
|
same as abuse plus uncontrolled use and tolerance and/or withdrawal Sx.
|
|
What's sensitization?
|
some substances (psychostimulants) may produce a progressive enhancement of motor or other responses
|
|
what's the evidence that substance abuse causes persistent changes in brain structure and fxn?
|
enduring nature of Sx
vulnerabilitity of repeated relapse, even in the absence of continued use these changes give rise to maladaptive behavior patterns |
|
what's the criteria for substance abuse?
|
w/o dependence (or history of) and includes one or more:
failure to fulfill major oblig use in hazardous situations legal problems use despite problems |
|
criteria for substance dependence?
|
maladaptive pattern, includes 3 or more in same 12 month period:
tolerance/withdrawal more use than intended unsuccessful attempt to cut down reduced other activities great deal of time spent on drug use cont'd use despite adverse consequences |
|
What does NAc stimulation cause?
|
induces craving (wanting or seeking) rather than "rush" or euphoria
|
|
Is DA the only trigger for drug related behaviors?
|
No, activation of Glu pathways and NAc AMPA receptors also may trigger
|
|
Which areas of the brain do conditioned drug cues stimulate?
|
amygdala
prefrontal limbic cortical regions |
|
What provides glut input to NAc?
|
amygdala
prefrontal limbic cortical regions |
|
A lesion in the amygdala prevents what?
|
association of stimuli w/ reinforcement value.
|
|
what does the orbital and medial prefrontal cortex have to do with drug behavior?
|
they recieve mesocortical DA input and process motivational cues (determine goal directed behavior) in response to food or addictive stimuli too.
|
|
What does the NAc integrate?
|
emotional nature and the intended direction with the contextual condition (via glu input)
amplified by appropriate motivation (via DA) to act on different specific NAc pathways |
|
What does the hippocampus and ventral subiculum do?
|
provide contextual background which conditioned reinforcement depends on
|
|
what do DAergic pathways encode?
|
motivational value or "incentive salience"
|
|
what is the reverberatory circuit that can be considered the neuroadaptive core of dependence?
Where is the integration center? |
the cortico-striato-pallido-thalamo-cortical loop.
The NAc may be the integration center in this forebrain addiction circuit? |
|
What biological factors influence whether addiction will develop w/ the 1st exposure?
|
1) intrinsic state and effect of the substance
2) magnitude of reward circuit response 3) degree of neural adaptation as consequence |
|
what is acamprosate?
|
a taurine derivative
modulates glu hyperactivity and drug craving during alcohol abstinence (b/c of NMDA R sensitivity during withdrawal) may inhibit neural plasticity necess for the learning of new behaviors and appropriate responses |
|
what's the main mechanism of action for the following:
1. opiates 2. cocaine 3. amphetamine 4. alcohol 5. marijuana 6. nicotine 7. hallucinogens 8 PCP |
Action:
1. agonist at mu opiod R's 2. inhibit MA, DA, 5-HT reuptake 3. stim MA, 5-HT trans and blk reuptake 4. activate GABAa and mu R inhibit NMDA R's 5. agonist at cannaboid GB4 R 6. agonist ACh nicotinic R 7. partial agon at cortical 5-HT2a R's 8. antag at cortical glu NMDA |
|
how much does genetics contribute to addiction?
|
30-60% of variablility of expression of addiction
multiple genetic variants work in concert to affect vulnerability and severity of addiction |
|
What % of the population drinks?
How many are alcoholics? |
50% over 18 consume alcohol but 5-10% account for 1/2 the consumption
12-18 million alcoholics and problem drinkers in the US |
|
How many people smoke in the US?
How many use Cocaine? Opiates? |
60 million smokers in US (29%)
2-3.5 million americans dependent on cocaine ~1 million heroin dependent and 2-4 mill depend on Rx opoids |
|
what are the health effects of drug addiction?
|
infections (hepatitis/HIV for heroin, cocaine, etc)
GI pain/bleeding, ulcers (EtOH) brain, periph neural damage, dementia (alcohol, stim) CV, stroke, MI (stim) |
|
what are the annual death rates for tobacco, alcohol and drugs/AIDS?
|
tobacco - 400,000
alcohol - 100,000 drugs/AIDS - 25,000 |
|
What are some 6 treatment models?
|
1. advice model and Brief intervention
2. Self-help model 3. cognitive-behavioral-motivation 4. biolog-pharmacol model 5. social models 6. dual-diag interventions |
|
what's detox?
|
short term, pharmacol tx for substance dependence
goal=prevent rebound fx of withdrawal (can be fatal) |
|
what are the tx outcomes for substance abuse disorders?
|
variable depending on the population
dual dx pts worse prognosis than psychiatric condition physician monitoring shown to be very effective (e.g CAGE) |
|
what's a rational-empirical approach to prevention?
|
disseminate facts and people will do what's in their own best interest (e.g. surgeon general's warning on smoking)
|
|
what's normative reductive strategy for demand reduction?
|
promote social norms around abstinence or responsible use (peer counseling, media)
|
|
what's the power coercive approach to demand reduction
|
enact laws to prohibit/limit certain drug use (limit distribution, increase taxes)
|
|
How does acamprosate help prevent alcohol relapse?
|
alcohol inhibits glutamate transmission leading to upregulation of the NMDA receptor. Acamprosate might work by maintaining the NMDA inhibition during periods when the subject is not intoxicated.
|
|
what are the average blood concentrations of alcohol after a drink?
|
One drink is about 14-16 g of alcohol: gives a concentration of 30 mg/dl (30 mg%)
This corresponds to about 6.5 mM. Legal intoxication is set at 17 mM which is 80 mg/dl. |
|
what's the lifetime prevalence of addiction? Is it common?
|
lifetime prevalence nearly 15%
|
|
What are some general concepts about addiction?
|
common
chronic and relapsing condition complex w/ multiple causes (psycho/bio/genetic contributors) Addiction is treatable |
|
what's the continuum of drug use?
|
initiation/intoxication
harmful use/abuse dependence/withdrawal relapse/craving recovery, persisting deficits |
|
what's substance intoxication?
|
reversible substance-specific syndrome due to recent substance exposure/ingestion
clinical changes due to the effect of the substance on the CNS during/shortly after use |
|
what's tolerance?
|
either:
a. need for markedly increased amounts to achieve same effect b. markedly diminished effect w/ cont'd use of same amount |
|
what's withdrawal?
|
either:
a. develop specific syndrome due to cessation or reduction after prolonged heavy use b. syndrome causes clinical distress or impairment |
|
where are the DA pathways in addiction?
|
from substantia nigra and ventral tegmental area to
NAc, prefrontal cx, cingulate gyrus, and striatum |
|
how much do natural rewards like food and sex elevate DA levels in the NAc?
How about drugs? |
food--150% baseline levels
sex--200% Amphetamine=1050% Cocaine=340% Nicotine=225% Morphine=200% Sustained |
|
1. With addiction, what brain area causes goal directed activity/ insight?
2. Cue and contextual conditioning? 3. Reward/reinforcement/ relapse |
1. Prefrontal Cx
2. Hippocampus 3. NAc |
|
1. Which brain area is most responsible for Action?
2. Motivation/salience of drugs 3. emotional and stress fx |
1. VP--input from NAc, projects to MD thalamus
2. VTA 3. amygdala - input from VTA, projects to NAc (w/ Glu) |
|
what are the factors predisposing to relapse?
|
physiological withdrawal > cue reactivity
time of abstinence is directly proportional to decreased risk of relapse |
|
what's the major cell type of both NAc and dorsal striatum?
|
the medium spiny neuron
|
|
what does the medium spiny neuron do?
|
DA-glutamate interxns in the striatum
it is characterized by dendritic spines which serve its fxn of integration: glu afferents from cerebral cx DA afferents from VTA and SN these come together at spines in NAc and dorsal striatum to integrate motivational info |
|
what drugs cause an increase of AMPA/NMDA ratio compared with baseline?
|
all drugs of abuse
reflects an increase in basal excitatory synaptic strength |
|
how is delta-FosB (a transcription factor) implicated in long term drug abuse?
How does it act? |
it's selectively induced.
delta-FosB binds regulatory regions (AP-1 sites) in target genes the AMPA R (GluR2) is an example of a gene regulated by its overexpression |
|
what are the principles of detox?
|
medical discontinuation of use of addictive substance and physio/mental readjustment
-oral medication -long duration of action -clear target Sx/signs |
|
how can you maximize motivation for abstinence?
|
-psychoeducation w/ pt and fam
-motivational enhancement therapy -Cog behavior Tx -Self Help groups (AA, NA) |
|
How is relapse prevented?
|
avoid high risk situation
anticipate minor relapse recover from relapses id triggers alternative coping strategies |
|
What are some drugs to reverse OD?
|
flumazenil
naloxone |
|
What are some drugs for detox?
|
chlordiazepoxide
methadone |
|
What are some pharmacological ways to prevent relapse?
|
substitution (methadone)
blockade (naltrexone for opioid) aversion (disulfiram) anti-craving (naltrexone/acamprosate) |
|
how are benzos used for EtOH detox?
|
titrate dose to Sx (chlordiazepoxide)
peak Sx at day 3 (last 7 d) oxazepam in older or liver impaired alcoholics can supplement w/ adrenergic blockers |
|
How does methadone maintenance for opioids work?
|
mu opioid agonist
significantly improves tx retention and decreased relapse x-tolerance to opioids start at 30 mg, increase to over 70 mg po q 1/day duration: 1-20 years |
|
How is buprenorphine used to prevent opioid relapse?
|
partial opioid agonist, x-tolerance
can be combined w/ naloxone comparable to methadone tx lower OD potential and liability less severe withdrawal than methadone can be prescribed in office |
|
What is used for nicotine detox and relapse prevention?
|
nicotine gum/patch/aerosol
bupropion varenicline |
|
Risks of naltrexone in alcoholism
|
6-10% initial dropout due to S/E (vomiting, nausea, anxiety)
lack of efficacy in severe alcohol dependence |
|
benefits of naltrexone in alcoholism?
|
~50% reduction in relapse risk
improved rating of employment problems relapse prevention > than 6 mo after discontinuation more abstinence at end-point and follow up |
|
How is acamprosate useful in EtOH relapse prevention?
|
helps maintain abstinence after detox
blocks craving modulates Glu NT system well tolerated, few S/E's |
|
24 yo college student smokes a drug. feels euphoria and power
collapses several mins later and has grand mal seizure at ED: pulseless and apneic, v fib. |
most likely crack or meth (free base)
blk reuptake of MA (DA, NE, 5-HT) severe S/Es: arrhyth, myo ischemia (stim β noradrenergicin heart and α in vasc) |
|
what system plays a crucial role in reinforcing the effects of psychostimulants?
|
mesolimbic DA systerm (project from VTA to NAc)
X-dependence w/ psychostims (amphetamines, morphine, heroin,opioids, cocaine) |
|
what's the withdrawal to psychostimulants?
|
relatively mild (vs opiate):
dysphoria fatigue unpleasant dreams insomnia incr apetite psychomotor agitation bradycardia DRUG CRAVING (most salient feauture) |
|
who uses psychostimulants?
|
all social classes
(similar rate among physicians as general pop) cocaine use 2:1 (m:f) (1:1 for crack) |
|
relapse rate among detoxed psychostim users?
|
HIGH,no effective pharmacological tx
current tx's: antidepressants (desipramine, fluoxetine) DA agonists, reuptake blkers (bromocriptine, mazindol) mixed opioid ag-antag (buprenorphine) anticonvulsant (carbamazepine) AA for alcoholics |
|
29 yo medical resident w/ access to drugs. began injecting w/ incr freq to relax (self medicate for problems w/ sleeplessness and anxiety)
fxned well at work, sometimes sluggish/inappropriate drank some EtOH-marked intox withdrawal: marked insomnia, anxiety, fatigue |
Benzo (vallium, librium)
tx for anxiety sedation at higher dose act at GABAa (but not GABAb) R's-bind directly to specific site on GABAa R/ion ch complex distinct from GABA binding site incr GABAa mediated Cl- conductance x-depend w/ benzos, barbs, EtOH |
|
benzo OD
|
very safe drugs but OD can be lethal w/ EtOH
|
|
side effects w/ benzos?
|
initial drowsiness but tolerance w/ use
|
|
benzo withdrawal
|
anxiety, agitation, paresthesias, muscle cramps, myoclonic jerks, sleep disturbance and dizziness
long-term use - more severe sx: seizures and delirium. |
|
who uses benzos
|
roughly the same among physicians (most common type of drug abuse) and gen pop
abuse usually starts w/ a physician's prescription |
|
how should a pt be detoxed from benzo?
|
slow withdrawal effective (may take months depending on length of use)
can use non-benzo anxiolyitic (buspirone) or long acting benzo (diazepam) many pts on low dose for yrs have few/no withdrawal sx |
|
opiate withdrawal
|
heroine/morphine:
protracted withdrawal (5-10 d), intense Sx: intense craving, restlessness, irritability, sens to pain, nausea, cramps, muscle aches, dysphoria, insom, anxiety, pupil dilation, sweating, piloerection, tachycardia, vomit, diarr, incr BP, yawn, fever. Methadone-slower onset and lasts longer. |
|
how do morphine and heroin work?
|
µ opioid R agonists
heroin: prodrug (conv to morph), rapid onset, more lipid sol (x's BBB faster), deacetylated in brain to morph stim VTA µ R's--euphoria, causes DA firing in NAc (reinforcing fx's) |
|
S/E's of opiates
|
miosis (excite Para nerve of pupil)
resp depression (direct fx on the BS resp centers--death from OD nearly always due to resp arrest) nausea,vomit-stim of area postrema-medulla, CTZ for emesis; release pit H's inhib in response to the stimulation of opiate R's in hypothal constipation-decr peristalsis at high doses-convulsions from inhib of GABAergic neur of CNS depress cough reflex |
|
sx of alcohol withdrawal
|
delirium tremens
impaired liver fxn (chronic alcoholism) |
|
mech of alcohol intox?
|
enhance transm through GABAa R's
excit and inhib Nic R's inhib NMDA and kainate R's ataxia, sedation by incr inhib trans (GABA) and decr excit trans (N ACh, NMDA, kainate glu R's) x toler to other sedatives (benzos) |
|
toxicity of EtOH
|
many organs:
liver dz CV dz endocrine/GI fx CNS dysfxn (depression, cognitive decline, memory impair) X's placenta (FAS--MR) |
|
EtOH withdrawal
|
craving, tremor, irritable, nausea, insomnia, tachycard, hypertxn, sweating, perceptual distortions, seizures and DTs.
Sx of DT's: agitation, confusion, hallucinations, fever, sweating, tachycardia, nausea, diarrhea, dilated pupils. DT's rare w/o other complications like infection, trauma, malnut or electrolyte imbal |
|
who uses alcohol
|
70% of American adults occasionally consume
lifetime prevalence of alcoholism is 5-10% for men and 3-5% for women among physicians is similar to the general public |
|
what should be done for EtOH withdrawal?
|
hydration, electrolytes and vitamins (especially thiamine).
Short-acting benzos to diminish EtOH withdrawal sx Long-acting benzos: use cautiously b/c of potential liver dz |
|
what can be done to treat alcoholism after detox?
|
AA for motivated alcoholics
disulfiram (if pt willing) naltrexone (blks reinforcing fx, lower relapse) acamprosate (lower relapse) |
|
MDMA intoxication sx
|
altered mental status, tachycardia, tachypnea, sweating, dry mouth, clench jaw, hypertherm
severe: rhabdomyolysis, acute renal fail, card collapse, malig hypertherm, hepatic fail, water tox |
|
pharmacology of MDMA
|
similar to other psychostims but greater affin for 5-HT and DA transporters
incr extracell DA in NAc x-depend w/ psychostims and opiates |
|
S/Es of MDMA
|
due to NE release in PNS:
tachycard, incr BP, mydriasis, tremor, palpitation, diaphoresis salivation, bruxism(teeth grind), trismus (lock jaw) (latter 2 fx due to 5-HT on CNV) |
|
effect of MDMA on the liver?
|
toxic: metab by CYP2D6 (approx 5% of pop deficient--predispose to hypertherm and liver tox)
|
|
fx of MDMA:
|
elevates mood, positive view of self, decr sleep, "love drug"
visual perceptual distortions |
|
withdrawal of MDMA?
|
unknown,
long actin--hangover effect (fatigue, drowsy, musc ache, difficulty conc, irritable) |
|
effects of MDMA on Serotonergic neurons in animals?
|
degeneration of serotonergic neurons after repeat exposure
still debated fx of neurotoxicity in humans. |